All In MedTech

Device Trial Radar · NCT03168659

CardioFocus HeartLight Post-Approval Study

Post-Approval Study of the HeartLight Endoscopic Ablation System for the Treatment of Atrial Fibrillation

Last checked: Nov 20, 2026Latest source record: Aug 20, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

250

Planned (sponsor's estimate)

Start

Jun 16, 2017

Primary completion

Oct 2026

Study completion Oct 2028

Sponsor

Lead sponsor
CardioFocusNot on our public-company list
Sponsor type
Industry
First posted
May 30, 2017

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a post-approval study to evaluate the clinical outcomes in a cohort of participants treated during commercial use of the HeartLight System to confirm results of the previously conducted pivotal clinical study.

Conditions

  • Atrial Fibrillation

Interventions

  • HeartLightDevice

    HeartLight Endoscopic Ablation System

  • AblationProcedure

    Pulmonary vein isolation ablation

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The proportion of participants free from symptomatic atrial fibrillation (AF) or symptomatic atypical atrial flutter/atrial tachycardia (AFL/AT) lasting longer than 30 seconds post the 90 day blanking periodTime frame: Day 91 through 12 months

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • University of Arizona Sarver HeartCenter

    Tucson, Arizona · Recruiting

  • University of Illinois

    Chicago, Illinois · Recruiting

  • Mount Sinai Hospital

    New York, New York · Recruiting

1 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.